TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
Overview
Affiliations
In 2005 a newly discovered T helper cell subset that secreted interleukin (IL)-17 became the center of attention in immunology. Initial studies painted Th17 cells as the culprit for destruction in many different autoimmune and auto-inflammatory diseases. Subsequently, the discovery of patients with primary immunodeficiencies in the IL-17 pathway taught us that Th17 cells have a critical role in defense against certain fungal and bacterial infections. Moreover, the paradoxical exacerbation of Crohn's disease in the clinical trials of a Secukinumab (AIN457), a fully human neutralizing antibody to IL-17A, has cast into doubt a universal pro-inflammatory and harmful role for Th17 cells. Evidence now suggests that depending on the environment Th17 cells can alter their differentiation program, ultimately giving rise to either protective or pro-inflammatory cells. In this review we will summarize the evidence from patients with immunodeficiencies, autoimmune, or auto-inflammatory diseases that teaches us how the pro-inflammatory versus protective function of Th17 cells varies within the context of different human diseases.
Oral Microbiome: A Review of Its Impact on Oral and Systemic Health.
Rajasekaran J, Krishnamurthy H, Bosco J, Jayaraman V, Krishna K, Wang T Microorganisms. 2024; 12(9).
PMID: 39338471 PMC: 11434369. DOI: 10.3390/microorganisms12091797.
Health Consequences of Thymus Removal in Adults.
Kooshesh K, Foy B, Sykes D, Gustafsson K, Scadden D N Engl J Med. 2023; 389(5):406-417.
PMID: 37530823 PMC: 10557034. DOI: 10.1056/NEJMoa2302892.
Bryan E, Trim L, Sadowski P, Paramasivan S, Kim J, Gough K Biol Reprod. 2023; 108(5):758-777.
PMID: 36799886 PMC: 10183362. DOI: 10.1093/biolre/ioad021.
Biometabolites of Peel Enhance Intestinal Permeability and Alter Gut Commensal Bacteria.
Lee S, Seo D, Lee K, Park S, Park S, Kim H Nutrients. 2023; 15(2).
PMID: 36678190 PMC: 9862503. DOI: 10.3390/nu15020319.
Distinct CD4+ T cell signature in ANA-positive young adult patients.
Zotti F, Moriconi C, Qiu A, Miller A, Hudson K Front Immunol. 2022; 13:972127.
PMID: 36311777 PMC: 9608560. DOI: 10.3389/fimmu.2022.972127.